NEW YORK, March 03, 2017 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Omega Protein Corporation (“Omega Protein” or the “Company”) (NYSE:OME) in the United States District Court for Central District of California on behalf of persons or entities who purchased Omega Protein stock on the open market from August 3, 2016 and March 1, 2017, inclusive (the “Class Period”), seeking to recover compensable damages caused by Defendants’ violations of the Securities Exchange Act of 1934.
The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that: (1) the SEC is requesting information in connection with an investigation relating to the Company’s subsidiary’s compliance with its probation terms and the Company’s protection of whistleblower employees; (2) it is possible that the foregoing matter could result in a material adverse effect on the Company’s business, reputation, results of operation and financial condition; and (3) consequently, Defendants’ statements about the Company’s business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times.
On March 1, 2017, post-market, the Company revealed that it had received a subpoena from the U.S. Securities and Exchange Commission seeking information about an investigation of the Company subsidiary’s compliance with its probation terms and the Company’s protection of whistleblower employees. Following this news, the Company stock dropped as much as $5.86 per share, or 22.32%, during intraday trading on March 2, 2017.
If you wish to serve as lead plaintiff, you must move the Court no later than May 2, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 



